A critical overview of long non-coding RNA in glioma etiology 2016: an update

Tumor Biology

Volumn 37, Issue 11, 2016, Pages 14403-14413

  Gao, Yuan Feng ^a,b   Wang, Zhi Bin ^a,b   Zhu, Tao ^a,b   Mao, Chen Xue ^a,b   Mao, Xiao Yuan ^a,b   Li, Ling ^a,b   Yin, Ji Ye ^a,b   Zhou, Hong Hao ^a,b   Liu, Zhao Qian ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Key Laboratory of Pharmacogenetics   (China)

Author keywords

Functional roles; Glioma; lncRNAs; Potential biomarkers and therapeutic targets

Indexed keywords

LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MICRORNA; RNA AB073614; RNA ATB; RNA GAS5; RNA H19; RNA HOTAIR; RNA HOXA11 AS; RNA HULC; RNA POU3F3; RNA ROR; RNA SPRY4 1T1; TAURINE UPREGULATED GENE 1; TUMOR MARKER; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CRNDE GENE; EPIGENETICS; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GLIOMA; HUMAN; INTERACTIONS WITH RNA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; GENETICS; PATHOLOGY;

BIOMARKERS, TUMOR; CENTRAL NERVOUS SYSTEM; DISEASE PROGRESSION; GLIOMA; HUMANS; RNA, LONG NONCODING;

EID: 84988416367     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-016-5307-4     Document Type: Review

References (107)

1. Lino MM, Merlo A, Boulay JL. Notch signaling in glioblastoma: a developmental drug target? BMC Med. 2010;8:72. doi:10.1186/1741-7015-8-72.
2. Altieri R, Agnoletti A, Quattrucci F, Garbossa D, Calamo Specchia FM, Bozzaro M, et al. Molecular biology of gliomas: present and future challenges. Transl Med UniSa. 2014;10:29–37.
3. Bhatt AN, Mathur R, Farooque A, Verma A, Dwarakanath BS. Cancer biomarkers—current perspectives. Indian J Med Res. 2010;132:129–49.
4. Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer. 2007;6:25. doi:10.1186/1476-4598-6-25.
5. Bleeker FE, Molenaar RJ, Leenstra S. Recent advances in the molecular understanding of glioblastoma. J Neuro-Oncol. 2012;108:11–27. doi:10.1007/s11060-011-0793-0.
6. Sun Y, Zhang W, Chen D, Lv Y, Zheng J, Lilljebjorn H, et al. A glioma classification scheme based on coexpression modules of EGFR and PDGFRA. Proc Natl Acad Sci U S A. 2014;111:3538–43. doi:10.1073/pnas.1313814111.
7. Resnier P, David S, Lautram N, Delcroix GJ, Clavreul A, Benoit JP, et al. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro. Int J Pharm. 2013;454:748–55. doi:10.1016/j.ijpharm.2013.04.001.
8. Paul I, Bhattacharya S, Chatterjee A, Ghosh MK. Current understanding on EGFR and Wnt/beta-catenin signaling in glioma and their possible crosstalk. Genes Cancer. 2013;4:427–46. doi:10.1177/1947601913503341.
9. Hua W, Yao Y, Chu Y, Zhong P, Sheng X, Xiao B, et al. The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma. J Neuro-Oncol. 2011;105:149–57. doi:10.1007/s11060-011-0572-y.
10. Liu J, Xu X, Feng X, Zhang B, Wang J. Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251. J Exp Clin Cancer Res. 2011;30:80. doi:10.1186/1756-9966-30-80.
11. Zhang B, Feng X, Wang J, Xu X, Lin N, Liu H. Combined antitumor effect of ad-bFGF-siRNA and ad-Vpr on the growth of xenograft glioma in nude mouse model. Pathol Oncol Res. 2011;17:237–42. doi:10.1007/s12253-010-9303-5.
12. Zhou Y, Jin G, Mi R, Dong C, Zhang J, Liu F. The methylation status of the platelet-derived growth factor-B gene promoter and its regulation of cellular proliferation following folate treatment in human glioma cells. Brain Res. 2014;1556:57–66. doi:10.1016/j.brainres.2014.01.045.
13. Liu KW, Hu B, Cheng SY. Platelet-derived growth factor receptor alpha in glioma: a bad seed. Chin J Cancer. 2011;30:590–602. doi:10.5732/cjc.011.10236.
14. Liang C, Guo S, Yang L. Effects of alltrans retinoic acid on VEGF and HIF1alpha expression in glioma cells under normoxia and hypoxia and its antiangiogenic effect in an intracerebral glioma model. Mol Med Rep. 2014;10:2713–9. doi:10.3892/mmr.2014.2543.
15. Li D, Li XP, Wang HX, Shen QY, Li XP, Wen L, et al. VEGF induces angiogenesis in a zebrafish embryo glioma model established by transplantation of human glioma cells. Oncol Rep. 2012;28:937–42. doi:10.3892/or.2012.1861.
16. Sinha S, Koul N, Dixit D, Sharma V, Sen E. IGF-1 induced HIF-1alpha-TLR9 cross talk regulates inflammatory responses in glioma. Cell Signal. 2011;23:1869–75. doi:10.1016/j.cellsig.2011.06.024.
17. Hsieh A, Ellsworth R, Hsieh D. Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. J Cell Physiol. 2011;226:1118–27. doi:10.1002/jcp.22433.
18. Drukala J, Urbanska K, Wilk A, Grabacka M, Wybieralska E, Del Valle L, et al. ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro. Mol Cancer. 2010;9:159. doi:10.1186/1476-4598-9-159.
19. Acharya S, Chatterjee S, Kumar P, Bhattacharjee M, Chaudhuri S, Chaudhuri S. Induction of G1 arrest in glioma cells by T11TS is associated with upregulation of Cip1/Kip1 and concurrent downregulation of cyclin D (1 and 3. Anti-Cancer Drugs. 2010;21:53–64. doi:10.1097/CAD.0b013e32833276e8.)
20. Sun YC, Wang J, Guo CC, Sai K, Wang J, Chen FR, et al. MiR-181b sensitizes glioma cells to teniposide by targeting MDM2. BMC Cancer. 2014;14:611. doi:10.1186/1471-2407-14-611.
21. Wang H, Yuan Z, Chen Z, Yao F, Hu Z, Wu B. Effect of quercetin on glioma cell U87 apoptosis and feedback regulation of MDM2-p53. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34:686–9.
22. Barton KL, Misuraca K, Cordero F, Dobrikova E, Min HD, Gromeier M, et al. PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS One. 2013;8:e77639. doi:10.1371/journal.pone.0077639.
23. Kumar S. P53 induction accompanying G2/M arrest upon knockdown of tumor suppressor HIC1 in U87MG glioma cells. Mol Cell Biochem. 2014;395:281–90. doi:10.1007/s11010-014-2137-9.
24. Robertson LB, Armstrong GN, Olver BD, Lloyd AL, Shete S, Lau C, et al. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation. Familial Cancer. 2010;9:413–21. doi:10.1007/s10689-010-9346-5.
25. Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Am J Med Genet. 2000;92:136–41.
26. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, et al. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 1999;9:469–79.
27. Palani M, Devan S, Arunkumar R, Vanisree AJ. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population. Med Oncol. 2011;28:S445–52. doi:10.1007/s12032-010-9671-4.
28. Wang MH, Lin CL, Zhang JJ, Weng ZP, Hu T, Xie Q, et al. Role of PTEN in cholera toxin-induced SWO38 glioma cell differentiation. Mol Med Rep. 2013;7:1912–8. doi:10.3892/mmr.2013.1434.
29. Errafiy R, Aguado C, Ghislat G, Esteve JM, Gil A, Loutfi M, et al. PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity. PLoS One. 2013;8:e83318. doi:10.1371/journal.pone.0083318.
30. Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P, et al. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene. 2000;19:2–12. doi:10.1038/sj.onc.1203251.
31. Mitlianga PG, Gomez-Manzano C, Kyritsis AP, Fueyo J. Overexpression of E2F-1 leads to bax-independent cell death in human glioma cells. Int J Oncol. 2002;21:1015–20.
32. Gomez-Manzano C, Lemoine MG, Hu M, He J, Mitlianga P, Liu TJ, et al. Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU. Int J Oncol. 2001;19:359–65.
33. Maruyama R, Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep. 2012;45:604–11.
34. Yan B, Wang ZH, Guo JT. The research strategies for probing the function of long noncoding RNAs. Genomics. 2012;99:76–80. doi:10.1016/j.ygeno.2011.12.002.
35. Nakagawa S, Kageyama Y. Nuclear lncRNAs as epigenetic regulators-beyond skepticism. Biochim Biophys Acta. 2014;1839:215–22. doi:10.1016/j.bbagrm.2013.10.009.
36. Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2001;2:986–91. doi:10.1093/embo-reports/kve230.
37. Lee C, Kikyo N. Strategies to identify long noncoding RNAs involved in gene regulation. Cell Biosci. 2012;2:37. doi:10.1186/2045-3701-2-37.
38. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–89. doi:10.1101/gr.132159.111.
39. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–41. doi:10.1016/j.cell.2009.02.006.
40. Wang X, Song X, Glass CK, Rosenfeld MG. The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs. Cold Spring Harb Perspect Biol. 2011;3:a003756. doi:10.1101/cshperspect.a003756.
41. van Bakel H, Hughes TR. Establishing legitimacy and function in the new transcriptome. Brief Funct Genomic Proteomic. 2009;8:424–36. doi:10.1093/bfgp/elp037.
42. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316:1484–8. doi:10.1126/science.1138341.
43. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31:4577–87. doi:10.1038/onc.2011.621.
44. Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, et al. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol. 2012;(40):2004–12. doi:10.3892/ijo.2012.1413.
45. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6. doi:10.1038/nature08975.
46. Zhang JX, Han L, Bao ZS, Wang YY, Chen LY, Yan W, et al. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol. 2013;(15):1595–603. doi:10.1093/neuonc/not131.
47. Pastori C, Kapranov P, Penas C, Peschansky V, Volmar CH, Sarkaria JN, et al. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation. Proc Natl Acad Sci U S A. 2015;112:8326–31. doi:10.1073/pnas.1424220112.
48. Ke J, Yao YL, Zheng J, Wang P, Liu YH, Ma J, et al. Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326. Oncotarget. 2015;6:21934–49. doi:10.18632/oncotarget.4290.
49. Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA. 2007;13:313–6. doi:10.1261/rna.351707.
50. Ariel I, de Groot N, Hochberg A. Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection. Am J Med Genet. 2000;91:46–50.
51. Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. BioEssays. 2010;32:473–80. doi:10.1002/bies.200900170.
52. Ariel I, Sughayer M, Fellig Y, Pizov G, Ayesh S, Podeh D, et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol. 2000;53:320–3.
53. Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, Coll J, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 2005;280:29625–36. doi:10.1074/jbc.M504033200.
54. Shi Y, Wang Y, Luan W, Wang P, Tao T, Zhang J, et al. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One. 2014;9:e86295. doi:10.1371/journal.pone.0086295.
55. Li C, Lei B, Huang S, Zheng M, Liu Z, Li Z, et al. H19 derived microRNA-675 regulates cell proliferation and migration through CDK6 in glioma. Am J Transl Res. 2015;7:1747–64.
56. Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, Nobrega MA, et al. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem. 2002;277:5548–55. doi:10.1074/jbc.M105708200.
57. Xu HS, Zong HL, Shang M, Ming X, Zhao JP, Ma C, et al. MiR-324-5p inhibits proliferation of glioma by target regulation of GLI1. Eur Rev Med Pharmacol Sci. 2014;18:828–32.
58. Ellis BC, Molloy PL, Graham LD. CRNDE: a long non-coding RNA involved in CanceR, neurobiology, and DEvelopment. Front Genet. 2012;3:270. doi:10.3389/fgene.2012.00270.
59. Zhang X, Sun S, JK P, Tsang AC, Lee D, Man VO, et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 2012;48:1–8. doi:10.1016/j.nbd.2012.06.004.
60. Mizoguchi M, Yoshimoto K, Ma X, Guan Y, Hata N, Amano T, et al. Molecular characteristics of glioblastoma with 1p/19q co-deletion. Brain Tumor Pathol. 2012;29:148–53. doi:10.1007/s10014-012-0107-z.
61. Wang Y, Wang Y, Li J, Zhang Y, Yin H, Han B. CRNDE a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett. 2015;367:122–8. doi:10.1016/j.canlet.2015.03.027.
62. Han Y, Zhou L, Wu T, Huang Y, Cheng Z, Li X, et al. Downregulation of lncRNA-MALAT1 affects proliferation and the expression of Stemness markers in glioma stem cell line SHG139S. Cell Mol Neurobiol. 2015. doi:10.1007/s10571-015-0303-6.
63. Ma J, Wang P, Yao Y, Liu Y, Li Z, Liu X, et al. Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140. Biochim Biophys Acta. 2016;1859:324–38. doi:10.1016/j.bbagrm.2015.11.008.
64. He C, Jiang B, Ma J, Li Q. Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients. APMIS. 2016;124:169–74. doi:10.1111/apm.12480.
65. Zhen L, Yun-Hui L, Hong-Yu D, Jun M, Yi-Long Y. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-met axis. Tumour Biol. 2016;37:673–83. doi:10.1007/s13277-015-3843-y.
66. Wang Q, Zhang J, Liu Y, Zhang W, Zhou J, Duan R, et al. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett. 2016;373:251–9. doi:10.1016/j.canlet.2016.01.039.
67. Guo H, Wu L, Yang Q, Ye M, Zhu X. Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma. Gene. 2015;554:114–9. doi:10.1016/j.gene.2014.10.038.
68. Zhu Y, Zhang X, Qi L, Cai Y, Yang P, Xuan G, et al. HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas. Oncotarget. 2016. doi:10.18632/oncotarget.7418.
69. Liu H, Lv Z, Guo E. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Int J Clin Exp Pathol. 2015;8:9140–6.
70. Ma CC, Xiong Z, Zhu GN, Wang C, Zong G, Wang HL, et al. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a. J Exp Clin Cancer Res. 2016;35:–90. doi:10.1186/s13046-016-0367-2.
71. Hu L, Lv QL, Chen SH, Sun B, Qu Q, Cheng L, et al. Up-regulation of long non-coding RNA AB073614 predicts a poor prognosis in patients with glioma. Int J Environ Res Public Health. 2016:13. doi:10.3390/ijerph13040433.
72. Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, Aisaka K, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000;5:211–20.
73. Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, et al. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology. 2010;151:939–47. doi:10.1210/en.2009-0657.
74. Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012;113:1868–74. doi:10.1002/jcb.24055.
75. Li J, Bian EB, He XJ, Ma CC, Zong G, Wang HL, et al. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas. Int J Oncol. 2016;48:723–33. doi:10.3892/ijo.2015.3285.
76. Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J, et al. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett. 2015;359:75–86. doi:10.1016/j.canlet.2014.12.051.
77. Qin X, Yao J, Geng P, Fu X, Xue J, Zhang Z. LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma. Int J Clin Exp Pathol. 2014;7:3065–72.
78. Yao J, Zhou B, Zhang J, Geng P, Liu K, Zhu Y, et al. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells. Tumour Biol. 2014;35:7935–44. doi:10.1007/s13277-014-1949-2.
79. Yue H, Zhu J, Xie S, Li F, Xu Q. MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma. Biomed Pharmacother. 2016;81:203–9. doi:10.1016/j.biopha.2016.03.002.
80. Li J, Zhang M. An G, Ma Q. LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis. Exp Biol Med (Maywood). 2016;241:644–9. doi:10.1177/1535370215622708.
81. Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y, et al. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget. 2015;6:19759–79. doi:10.18632/oncotarget.4331.
82. Feng S, Yao J, Chen Y, Geng P, Zhang H, Ma X, et al. Expression and functional role of reprogramming-related long noncoding RNA (lincRNA-ROR) in glioma. J Mol Neurosci. 2015;56:623–30. doi:10.1007/s12031-014-0488-z.
83. Zhao X, Wang P, Liu J, Zheng J, Liu Y, Chen J, et al. Gas5 exerts tumor-suppressive functions in human glioma cells by targeting miR-222. Mol Ther. 2015;23:1899–911. doi:10.1038/mt.2015.170.
84. Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J, et al. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal. 2015;27:275–82. doi:10.1016/j.cellsig.2014.11.011.
85. Weirick T, John D, Dimmeler S, Uchida S. C-it-loci: a knowledge database for tissue-enriched loci. Bioinformatics. 2015;31:3537–43. doi:10.1093/bioinformatics/btv410.
86. Zhao Z, Bai J, Wu A, Wang Y, Zhang J, Wang Z, et al. Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-seq data. Database (Oxford). 2015. doi:10.1093/database/bav082.
87. Yang JH, Li JH, Jiang S, Zhou H, Qu LH. ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-seq data. Nucleic Acids Res. 2013;41:D177–87. doi:10.1093/nar/gks1060.
88. Liu C, Bai B, Skogerbo G, Cai L, Deng W, Zhang Y, et al. NONCODE: an integrated knowledge database of non-coding RNAs. Nucleic Acids Res. 2005;33:D112–5. doi:10.1093/nar/gki041.
89. Zhao Y, Li H, Fang S, Kang Y, Wu W, Hao Y, et al. NONCODE 2016: an informative and valuable data source of long non-coding RNAs. Nucleic Acids Res. 2016;44:D203–8. doi:10.1093/nar/gkv1252.
90. Chakraborty S, Deb A, Maji RK, Saha S, Ghosh Z. LncRBase: an enriched resource for lncRNA information. PLoS One. 2014;9:e108010. doi:10.1371/journal.pone.0108010.
91. Amaral PP, Clark MB, Gascoigne DK, Dinger ME, Mattick JS. lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res. 2011;39:D146–51. doi:10.1093/nar/gkq1138.
92. Quek XC, Thomson DW, Maag JL, Bartonicek N, Signal B, Clark MB, et al. lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs. Nucleic Acids Res. 2015;43:D168–73. doi:10.1093/nar/gku988.
93. Bhartiya D, Pal K, Ghosh S, Kapoor S, Jalali S, Panwar B, et al. lncRNome: a comprehensive knowledgebase of human long noncoding RNAs. Database (Oxford). 2013;2013:bat034. doi:10.1093/database/bat034.
94. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-seq and Degradome-seq data. Nucleic Acids Res. 2011;39:D202–9. doi:10.1093/nar/gkq1056.
95. Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-seq data. Nucleic Acids Res. 2014;42:D92–7. doi:10.1093/nar/gkt1248.
96. Volders PJ, Helsens K, Wang X, Menten B, Martens L, Gevaert K, et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res. 2013;41:D246–51. doi:10.1093/nar/gks915.
97. Volders PJ, Verheggen K, Menschaert G, Vandepoele K, Martens L, Vandesompele J, et al. An update on LNCipedia: a database for annotated human lncRNA sequences. Nucleic Acids Res. 2015;43:4363–4. doi:10.1093/nar/gkv295.
98. Jiang Q, Ma R, Wang J, Wu X, Jin S, Peng J, et al. LncRNA2Function: a comprehensive resource for functional investigation of human lncRNAs based on RNA-seq data. BMC Genomics. 2015;16:S2. doi:10.1186/1471-2164-16-s3-s2.
99. Gong J, Liu W, Zhang J, Miao X, Guo AY. lncRNASNP: a database of SNPs in lncRNAs and their potential functions in human and mouse. Nucleic Acids Res. 2015;43:D181–6. doi:10.1093/nar/gku1000.
100. Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2013;41:D983–6. doi:10.1093/nar/gks1099.
101. Ning S, Zhang J, Wang P, Zhi H, Wang J, Liu Y, et al. Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers. Nucleic Acids Res. 2016;44:D980–5. doi:10.1093/nar/gkv1094.
102. Liu K, Yan Z, Li Y, Sun Z. Linc2GO: a human lncRNA function annotation resource based on ceRNA hypothesis. Bioinformatics. 2013;29:2221. doi:10.1093/bioinformatics/btt361.
103. Jeggari A, Marks DS, Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics. 2012;28:2062–3. doi:10.1093/bioinformatics/bts344.
104. Paraskevopoulou MD, Georgakilas G, Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM, et al. DIANA-lncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res. 2013;41:D239–45. doi:10.1093/nar/gks1246.
105. Paraskevopoulou MD, Vlachos IS, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T, et al. DIANA-lncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016;44:D231–8. doi:10.1093/nar/gkv1270.
106. Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao Z, et al. Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer. Nucleic Acids Res. 2015;43:3478–89. doi:10.1093/nar/gkv233.
107. Chang TH, Huang HY, Hsu JB, Weng SL, Horng JT, Huang HD. An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinforma. 2013;(14):S4. doi:10.1186/1471-2105-14-s2-s4.